Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC100132015///ODZ1///SH2D1A |
| Upstream (Parents) |
|---|
| (<<) GLYAT → LOC100132015///ODZ1///SH2D1A |
| (<<) AR → LOC100132015///ODZ1///SH2D1A |
| (<<) PECR → LOC100132015///ODZ1///SH2D1A |
| Downstream (Children) |
|---|
| LOC100132015///ODZ1///SH2D1A → SLCO4C1 (>>) |
| LOC100132015///ODZ1///SH2D1A → PER1 (>>) |
| LOC100132015///ODZ1///SH2D1A → DNALI1 (>>) |
| LOC100132015///ODZ1///SH2D1A → CELF2 (>>) |
| LOC100132015///ODZ1///SH2D1A → PIR (>>) |
| LOC100132015///ODZ1///SH2D1A → SP100 (>>) |
| LOC100132015///ODZ1///SH2D1A → PACRG (>>) |
| LOC100132015///ODZ1///SH2D1A → PAX4 (>>) |
| LOC100132015///ODZ1///SH2D1A → OTUB2 (>>) |
